Department of Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cancer Imaging. 2024 Mar 20;24(1):39. doi: 10.1186/s40644-024-00681-z.
Primary thyroid lymphoma (PTL) is a rare malignant disorder, and ultrasound plays an important role in PTL diagnosis and follow-up surveillance. Prediction of refractory/relapse events in PTL patients is an essential issue, yet no ultrasonic PTL features have been discovered to be related to refractory/local relapse events.
From January 2008 to September 2022, newly diagnosed PTL patients in our center who underwent standard first-line treatment and received an ultrasound examination before treatment were enrolled. Data regarding patients' clinical and sonographic features, as well as their therapeutic responses were collected. Subjects with an ideal prognosis were compared to those with refractory/relapse events.
In total, 37 PTL patients were analyzed, including 26 with diffuse large B-cell lymphoma, 2 with follicular lymphoma and 9 with mucosa-associated lymphoid tissue lymphoma. During the median follow-up of 25 months, 30 patients obtained a complete response, 4 were refractory patients, and 3 experienced local relapse. No significant difference was detected in the baseline clinical characteristics between patients with an ideal prognosis and those with refractory/local relapse events. In terms of sonographic features, however, an event-free survival (EFS) curve comparison revealed that patients with bilobar enlargement (defined as an anterior-posterior diameter > 2.5 cm on both sides of thyroid lobes) had a poorer EFS than those without (P < 0.0001), and patients with diffuse type had a poorer EFS than those with mixed/nodular types (P = 0.043). No significant difference was observed in EFS between patients with or without signs of suspicious cervical lymph node metastasis, rich blood signal distribution or symptoms of trachea compression.
PTL patients with an anterior-posterior diameter > 2.5 cm for both thyroid lobes or PTL patients of the diffuse ultrasound type could be prone to refractory/local relapse events.
原发性甲状腺淋巴瘤(PTL)是一种罕见的恶性疾病,超声在 PTL 的诊断和随访监测中发挥着重要作用。预测 PTL 患者的难治/复发事件是一个重要问题,但尚未发现与难治/局部复发事件相关的超声 PTL 特征。
本研究纳入了 2008 年 1 月至 2022 年 9 月期间在我中心接受标准一线治疗并在治疗前接受超声检查的新诊断 PTL 患者。收集了患者的临床和超声特征以及治疗反应数据。将预后良好的患者与难治/复发的患者进行比较。
共分析了 37 例 PTL 患者,其中弥漫性大 B 细胞淋巴瘤 26 例,滤泡性淋巴瘤 2 例,黏膜相关淋巴组织淋巴瘤 9 例。在中位随访 25 个月期间,30 例患者获得完全缓解,4 例患者为难治患者,3 例患者发生局部复发。预后良好的患者与难治/局部复发的患者在基线临床特征方面无显著差异。然而,在超声特征方面,无事件生存(EFS)曲线比较显示,双侧甲状腺叶前后径>2.5cm(定义为甲状腺叶两侧前后径>2.5cm)的患者 EFS 较差(P<0.0001),弥漫型患者 EFS 较混合/结节型患者差(P=0.043)。EFS 与可疑颈部淋巴结转移、丰富的血流信号分布或气管压迫症状之间无显著差异。
双侧甲状腺叶前后径>2.5cm 的 PTL 患者或弥漫型超声类型的 PTL 患者可能容易发生难治/局部复发事件。